# KYMERA THERAPEUTICS INC (KYMR)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/KYMR/

- Reporting holders: 4
- Reported value: $109.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $91.0K | 814 | 0.0% | 12 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $12.5K | 112 | 0.0% | 3 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $4.8K | 43 | 0.0% | 12 |
| [Marquette Asset Management, LLC](https://holderbook.com/funds/1395067-marquette-asset-management-llc/) | $671 | 6 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $109.0K |
| Q2 2026 | 288 | $11.6B |
| Q1 2026 | 259 | $8.0B |
| Q4 2025 | 257 | $7.0B |
| Q3 2025 | 211 | $4.6B |
| Q2 2025 | 213 | $3.5B |
| Q1 2025 | 178 | $2.0B |
| Q4 2024 | 180 | $2.9B |
| Q3 2024 | 177 | $3.3B |
| Q2 2024 | 157 | $2.0B |
| Q1 2024 | 164 | $2.8B |
| Q4 2023 | 138 | $1.6B |